High-sensitivity Cardiac Troponin and Natriuretic Peptide in Persons Without Cardiovascular Disease and Subsequent Risk of Infection: Atherosclerosis Risk in Communities Study.
Whether persons without prevalent cardiovascular disease (CVD) but elevated levels of high-sensitivity cardiac troponin T (hs-cTnT) or N-terminal pro-B-type natriuretic peptide (NTproBNP) are at high risk of infection is unknown. In the Atherosclerosis Risk in Communities Study, we estimated the hazard ratios (HRs) of incident hospitalization with infection in relation to plasma hs-cTnT and NTproBNP among participants without prevalent CVD, and contrasted with those with prevalent CVD (coronary heart disease, heart failure, stroke) from 1996 through 2013. In multivariable Cox model, prevalent CVD was significantly associated with risk of infection (HR, 1.31 [95%CI,1.19,1.45]). Among participants without prevalent CVD, hs-cTnT and NTproBNP were independently associated with infection risk in a graded fashion (e.g., HR 1.44 [1.24,1.69] for hs-cTnT ≥14ng/L and 1.28 [1.14,1.44] for 9-13ng/L vs. <3ng/L; and 1.57 [1.35,1.81] for NTproBNP ≥248.1pg/mL and 1.19 [1.06,1.34] for 137.2-248.0pg/mL vs. <48.1pg/mL). The 15-year cumulative incidence of hospitalization with infection was similar between participants with prevalent CVD and those without prevalent CVD but had hs-cTnT ≥14ng/L or NTproBNP ≥248.1pg/mL. Thus, hs-cTnT and NTproBNP were independently associated with infection risk. Persons without CVD but with elevated levels of hs-cTnT or NTproBNP should be recognized to have a similar infection risk as those with prevalent CVD.